Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease

NCT05951192 is registered in ClinicalTrials.gov with USRC Kidney Research as lead sponsor.

NCT NCT05951192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05951192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
Lead sponsor
USRC Kidney Research
Phase
Phase 4
Overall status
Completed
Start date
July 1, 2023
Completion date
February 14, 2024
Enrollment
161 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, renal anemia, renal insufficiency, chronic